HC Wainwright & Co. Reiterates Buy on Rein Therapeutics, Maintains $8 Price Target

Benzinga · 1d ago
HC Wainwright & Co. analyst Brandon Folkes reiterates Rein Therapeutics (NASDAQ:RNTX) with a Buy and maintains $8 price target.